$SGNT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sagent Pharmaceuticals, Inc.. Get notifications about new insider transactions in Sagent Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Buy | M | 0.00 | 930 | 0 | 5,080 | 4.2 K to 5.1 K (+22.41 %) | |
Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 0.00 | 634 | 0 | 54,924 | 55.6 K to 54.9 K (-1.14 %) |
Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 15.16 | 452 | 6,852 | 41,958 | 42.4 K to 42 K (-1.07 %) |
Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 15.16 | 542 | 8,217 | 23,740 | 24.3 K to 23.7 K (-2.23 %) |
Apr 25 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 17 | 230 | 25,320 | 25.3 K to 25.3 K (-0.07 %) |
Apr 25 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 2,299 | 31,151 | 3,456,332 | 3.5 M to 3.5 M (-0.07 %) |
Apr 25 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 13.55 | 23 | 312 | 34,961 | 35 K to 35 K (-0.07 %) |
Apr 25 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 13.55 | 1,982 | 26,856 | 2,978,803 | 3 M to 3 M (-0.07 %) |
Apr 18 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Option Exercise | M | 0.00 | 742 | 0 | 2,228 | ||
Apr 18 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Buy | M | 0.00 | 742 | 0 | 742 | 0 to 742 | |
Jan 05 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 15.85 | 853 | 13,520 | 24,282 | 25.1 K to 24.3 K (-3.39 %) |
Jan 05 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO and ... | Payment of Exercise | F | 15.85 | 924 | 14,645 | 55,558 | 56.5 K to 55.6 K (-1.64 %) |
Jan 05 2016 | SGNT | Sagent Pharmaceuti ... | SHEA THOMAS JOSEPH | VP, Global Alliance ... | Payment of Exercise | F | 15.85 | 853 | 13,520 | 4,627 | 5.5 K to 4.6 K (-15.57 %) |
Jan 05 2016 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 15.85 | 853 | 13,520 | 32,529 | 33.4 K to 32.5 K (-2.56 %) |
Dec 02 2015 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Option Exercise | A | 24.58 | 110,020 | 2,704,292 | 110,020 | |
Dec 02 2015 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Grant | A | 0.00 | 54,922 | 0 | 54,922 | 0 to 54.9 K |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 15.45 | 3,898 | 60,224 | 25,337 | 29.2 K to 25.3 K (-13.33 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 15.45 | 532,119 | 8,221,239 | 3,458,631 | 4 M to 3.5 M (-13.33 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 16.32 | 490 | 7,997 | 29,235 | 29.7 K to 29.2 K (-1.65 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 16.32 | 66,793 | 1,090,062 | 3,990,750 | 4.1 M to 4 M (-1.65 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 16.87 | 680 | 11,471 | 29,725 | 30.4 K to 29.7 K (-2.24 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 16.87 | 92,843 | 1,566,215 | 4,057,543 | 4.2 M to 4.1 M (-2.24 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 15.45 | 5,382 | 83,152 | 34,984 | 40.4 K to 35 K (-13.33 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 15.45 | 458,601 | 7,085,385 | 2,980,785 | 3.4 M to 3 M (-13.33 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 16.32 | 675 | 11,016 | 40,366 | 41 K to 40.4 K (-1.64 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 16.32 | 57,565 | 939,461 | 3,439,386 | 3.5 M to 3.4 M (-1.65 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 16.87 | 939 | 15,840 | 41,041 | 42 K to 41 K (-2.24 %) |
Nov 04 2015 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | S | 16.87 | 80,015 | 1,349,813 | 3,496,951 | 3.6 M to 3.5 M (-2.24 %) |
Jul 14 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | M | 0.00 | 592 | 0 | 1,183 | |
Jul 14 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Buy | M | 0.00 | 592 | 0 | 2,113 | 1.5 K to 2.1 K (+38.92 %) |
May 13 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President | Option Exercise | M | 4.31 | 2,759 | 11,891 | 10,000 | |
May 13 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President | Buy | M | 4.31 | 2,759 | 11,891 | 56,482 | 53.7 K to 56.5 K (+5.14 %) |
Apr 17 2015 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 2,970 | 0 | 2,970 | |
Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
Apr 13 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | A | 0.00 | 921 | 0 | 921 | |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Director | Gift | G | 0.00 | 48,850 | 0 | 616,076 | 664.9 K to 616.1 K (-7.35 %) |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Grant | A | 0.00 | 5,480 | 0 | 25,135 | 19.7 K to 25.1 K (+27.88 %) |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 5,480 | 0 | 53,723 | 48.2 K to 53.7 K (+11.36 %) |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 5,480 | 0 | 42,410 | 36.9 K to 42.4 K (+14.84 %) |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Grant | A | 0.00 | 5,480 | 0 | 33,382 | 27.9 K to 33.4 K (+19.64 %) |
Mar 19 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 27.32 | 66 | 1,803 | 36,930 | 37 K to 36.9 K (-0.18 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Option Exercise | A | 27.15 | 18,468 | 501,406 | 18,468 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Grant | A | 0.00 | 9,945 | 0 | 686,014 | 676.1 K to 686 K (+1.47 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Option Exercise | A | 27.15 | 9,234 | 250,703 | 9,234 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Grant | A | 0.00 | 4,972 | 0 | 11,058 | 6.1 K to 11.1 K (+81.70 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Grant | A | 0.00 | 4,420 | 0 | 19,655 | 15.2 K to 19.7 K (+29.01 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 4,420 | 0 | 48,243 | 43.8 K to 48.2 K (+10.09 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Option Exercise | A | 27.15 | 6,840 | 185,706 | 6,840 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Grant | A | 0.00 | 3,683 | 0 | 27,902 | 24.2 K to 27.9 K (+15.21 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 4,420 | 0 | 36,996 | 32.6 K to 37 K (+13.57 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | A | 27.15 | 6,840 | 185,706 | 6,840 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | A | 0.00 | 1,841 | 0 | 1,841 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 567 | 0 | 4,150 | 3.6 K to 4.2 K (+15.82 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 760 | 0 | 3,583 | 2.8 K to 3.6 K (+26.92 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 28.50 | 293 | 8,351 | 24,219 | 24.5 K to 24.2 K (-1.20 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 28.50 | 449 | 12,797 | 24,512 | 25 K to 24.5 K (-1.80 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 567 | 0 | 9,253 | 8.7 K to 9.3 K (+6.53 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 760 | 0 | 8,686 | 7.9 K to 8.7 K (+9.59 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 567 | 0 | 4,150 | 3.6 K to 4.2 K (+15.82 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 760 | 0 | 3,583 | 2.8 K to 3.6 K (+26.92 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 567 | 0 | 567 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 760 | 0 | 1,520 | |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 567 | 0 | 36,909 | 36.3 K to 36.9 K (+1.56 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 760 | 0 | 36,342 | 35.6 K to 36.3 K (+2.14 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 429 | 12,227 | 43,823 | 44.3 K to 43.8 K (-0.97 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 637 | 18,155 | 44,252 | 44.9 K to 44.3 K (-1.42 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 28.50 | 336 | 9,576 | 32,576 | 32.9 K to 32.6 K (-1.02 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 28.50 | 610 | 17,385 | 32,912 | 33.5 K to 32.9 K (-1.82 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 28.50 | 395 | 11,258 | 15,235 | 15.6 K to 15.2 K (-2.53 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 28.50 | 586 | 16,701 | 15,630 | 16.2 K to 15.6 K (-3.61 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 28.50 | 918 | 26,163 | 676,069 | 677 K to 676.1 K (-0.14 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 28.50 | 1,227 | 34,970 | 676,987 | 678.2 K to 677 K (-0.18 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 930 | 0 | 2,823 | 1.9 K to 2.8 K (+49.13 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Executive VP, Sales | Payment of Exercise | F | 27.22 | 452 | 12,303 | 24,961 | 25.4 K to 25 K (-1.78 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Buy | M | 0.00 | 930 | 0 | 1,521 | 591 to 1.5 K (+157.36 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 930 | 0 | 7,926 | 7 K to 7.9 K (+13.29 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Payment of Exercise | F | 27.22 | 610 | 16,604 | 6,086 | 6.7 K to 6.1 K (-9.11 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 930 | 0 | 2,823 | 1.9 K to 2.8 K (+49.13 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 930 | 0 | 2,790 | |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 930 | 0 | 35,582 | 34.7 K to 35.6 K (+2.68 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 27.22 | 581 | 15,815 | 44,889 | 45.5 K to 44.9 K (-1.28 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Payment of Exercise | F | 27.22 | 452 | 12,303 | 33,522 | 34 K to 33.5 K (-1.33 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 27.22 | 542 | 14,753 | 16,216 | 16.8 K to 16.2 K (-3.23 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 27.22 | 1,053 | 28,663 | 678,214 | 679.3 K to 678.2 K (-0.16 %) |
Jan 28 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 26.19 | 50,000 | 1,309,475 | 3,147,052 | 3.2 M to 3.1 M (-1.56 %) |
Jan 28 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 26.12 | 28,041 | 732,313 | 3,197,052 | 3.2 M to 3.2 M (-0.87 %) |
Jan 26 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.90 | 61,883 | 1,602,912 | 3,225,093 | 3.3 M to 3.2 M (-1.88 %) |
Jan 26 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.49 | 150,000 | 3,823,140 | 3,286,976 | 3.4 M to 3.3 M (-4.36 %) |
Jan 22 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.22 | 44,316 | 1,117,645 | 3,436,976 | 3.5 M to 3.4 M (-1.27 %) |
Jan 22 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.24 | 25,000 | 630,933 | 3,481,292 | 3.5 M to 3.5 M (-0.71 %) |
Jan 20 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.26 | 50,000 | 1,262,900 | 3,506,292 | 3.6 M to 3.5 M (-1.41 %) |
Jan 20 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.10 | 75,000 | 1,882,500 | 3,556,292 | 3.6 M to 3.6 M (-2.07 %) |
Jan 15 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.53 | 50,000 | 1,276,695 | 3,631,292 | 3.7 M to 3.6 M (-1.36 %) |
Jan 15 2015 | SGNT | Sagent Pharmaceuti ... | MORGAN STANLEY INVESTMENT MANA ... | 10% Owner | Sell | S | 25.49 | 50,000 | 1,274,635 | 3,681,292 | 3.7 M to 3.7 M (-1.34 %) |
Dec 30 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Gift | G | 0.00 | 300 | 0 | 45,470 | 45.8 K to 45.5 K (-0.66 %) |
Oct 23 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 31.99 | 8,000 | 255,920 | 433,770 | 441.8 K to 433.8 K (-1.81 %) |
Oct 08 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 31.96 | 8,000 | 255,680 | 441,770 | 449.8 K to 441.8 K (-1.78 %) |
Oct 08 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 31.15 | 8,000 | 249,200 | 449,770 | 457.8 K to 449.8 K (-1.75 %) |
Sep 25 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 29.72 | 8,000 | 237,760 | 457,770 | 465.8 K to 457.8 K (-1.72 %) |
Sep 25 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 30.30 | 8,000 | 242,400 | 465,770 | 473.8 K to 465.8 K (-1.69 %) |
Sep 12 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 28.25 | 8,000 | 226,000 | 473,770 | 481.8 K to 473.8 K (-1.66 %) |
Sep 12 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 28.35 | 8,000 | 226,800 | 481,770 | 489.8 K to 481.8 K (-1.63 %) |
Aug 29 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 27.07 | 8,000 | 216,560 | 489,770 | 497.8 K to 489.8 K (-1.61 %) |
Aug 29 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 27.30 | 8,000 | 218,400 | 497,770 | 505.8 K to 497.8 K (-1.58 %) |
Aug 13 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 24.39 | 8,000 | 195,120 | 505,770 | 513.8 K to 505.8 K (-1.56 %) |
Aug 13 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 24.39 | 8,000 | 195,120 | 513,770 | 521.8 K to 513.8 K (-1.53 %) |
Aug 07 2014 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | M | 0.00 | 591 | 0 | 1,775 | |
Aug 07 2014 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Buy | M | 0.00 | 591 | 0 | 591 | 0 to 591 |
Jul 21 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 26.11 | 8,000 | 208,880 | 537,770 | 545.8 K to 537.8 K (-1.47 %) |
Jul 21 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 26.25 | 8,000 | 210,000 | 545,770 | 553.8 K to 545.8 K (-1.44 %) |
Jul 31 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 25.20 | 8,000 | 201,600 | 521,770 | 529.8 K to 521.8 K (-1.51 %) |
Jul 31 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 26.00 | 8,000 | 208,000 | 529,770 | 537.8 K to 529.8 K (-1.49 %) |
Jul 29 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.31 | 12,759 | 54,991 | 0 | |
Jul 29 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.31 | 12,759 | 54,991 | 45,770 | 33 K to 45.8 K (+38.65 %) |
Jul 02 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 26.70 | 8,000 | 213,600 | 553,770 | 561.8 K to 553.8 K (-1.42 %) |
Jul 02 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 26.31 | 8,000 | 210,480 | 561,770 | 569.8 K to 561.8 K (-1.40 %) |
Jun 27 2014 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Gift | G | 0.00 | 5,200 | 0 | 33,974 | 39.2 K to 34 K (-13.27 %) |
Jun 18 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 23.26 | 8,000 | 186,080 | 569,770 | 577.8 K to 569.8 K (-1.38 %) |
Jun 18 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 23.47 | 8,000 | 187,760 | 577,770 | 585.8 K to 577.8 K (-1.37 %) |
Jun 04 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 22.29 | 8,000 | 178,320 | 585,770 | 593.8 K to 585.8 K (-1.35 %) |
Jun 04 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 22.05 | 8,000 | 176,400 | 593,770 | 601.8 K to 593.8 K (-1.33 %) |
May 23 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | S | 22.02 | 8,000 | 176,160 | 601,770 | 609.8 K to 601.8 K (-1.31 %) |
Mar 21 2014 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Option Exercise | A | 23.78 | 1,459 | 34,695 | 1,459 | |
Mar 21 2014 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 841 | 0 | 39,174 | 38.3 K to 39.2 K (+2.19 %) |
Feb 28 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 21.43 | 2,021 | 43,310 | 33,011 | 35 K to 33 K (-5.77 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 21.75 | 423 | 9,200 | 16,758 | 17.2 K to 16.8 K (-2.46 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 21.84 | 566 | 12,361 | 17,181 | 17.7 K to 17.2 K (-3.19 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 21.75 | 955 | 20,771 | 679,267 | 680.2 K to 679.3 K (-0.14 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 21.84 | 1,279 | 27,933 | 680,222 | 681.5 K to 680.2 K (-0.19 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Corporate VP, Sales | Payment of Exercise | F | 21.75 | 290 | 6,308 | 25,413 | 25.7 K to 25.4 K (-1.13 %) |